Company Description

IBIS is defining the future of precision by guiding drugs toward beneficial on-targets and away from harmful off-targets. Its AI-driven Molecular Fingerprint™ Platform engine enables valuable insights into information about drug candidates with the potential for maximum efficacy and safety.